Hit Discovery for Public Target Programs in the European Lead Factory: Experiences and Output from Assay Development and Ultra-High-Throughput Screening

The European Lead Factory (ELF) consortium provides European academics and small and medium enterprises access to ~0.5 million unique compounds, a state-of-the-art ultra-high-throughput screening (u-HTS) platform, and industrial early drug discovery (DD) expertise with the aim of delivering innovati...

Descripción completa

Detalles Bibliográficos
Autores principales: Honarnejad, Saman, van Boeckel, Stan, van den Hurk, Helma, van Helden, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637381/
https://www.ncbi.nlm.nih.gov/pubmed/32734803
http://dx.doi.org/10.1177/2472555220942765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637381/
https://www.ncbi.nlm.nih.gov/pubmed/32734803
http://dx.doi.org/10.1177/2472555220942765

Ejemplares similares